News
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.
FDA asks mRNA vaccine makers to widen age range for rare heart risk warning
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA vaccines to widen the age range of boys and young men that their labels say are at risk for a rare side effect causing heart inflammation.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...
Live Science on MSN3d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
MySuncoast.com on MSN4d
New Novavax Covid -19 vaccine tailored for patients 65 and olderAfter a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback